Position in ACIU
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$809,394
-$263,558 QoQ
Shares Held
340,082
-12.8% QoQ
Ownership
0.342%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 43 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 75%
Shared 22%
None 4%
Common Shares in ACIU Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,163,799,259 across 230 Biotechnology names. ACIU ranks #166 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in ACIU
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $809,394 | 340,082 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,072,952 | 390,165 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $670,276 | 213,464 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $511,849 | 177,111 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $403,331 | 198,686 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $444,232 | 237,558 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $354,806 | 131,410 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $215,655 | 57,052 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $240,189 | 60,198 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $176,865 | 59,752 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $298,760 | 59,752 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $170,293 | 59,752 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $180,112 | 60,952 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $108,217 | 46,247 | Shares | Sole | 2023-05-12 | |
| 2022-06-30 | $45,871 | 12,707 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $50,828 | 12,707 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $62,899 | 12,707 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $85,263 | 12,707 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $100,766 | 12,707 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $96,700 | 12,707 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $65,695 | 12,707 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $62,010 | 12,707 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $85,518 | 12,707 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $78,027 | 11,292 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||